Drug · DIN 02320193
SPRYCEL
FILM-COATED
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 4, 2009; first marketed May 4, 2009.
- Drug Identification Number (DIN)
- 02320193
- Company (DIN owner)
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Dasatinib L01EA02
- Class
- Human
- Record last updated
- July 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DASATINIB (DASATINIB MONOHYDRATE) | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 9, 2008: NOC 9931Supplement to a New Drug Submission (SNDS) · New strength: 100 mg Tablet.
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “sprycel”. A notice may cover another product or only some lots: read it to see what it covers.
Other DINs named SPRYCEL
- DIN 02293129 · Marketed
- DIN 02293137 · Marketed
- DIN 02293145 · Marketed
- DIN 02360810 · Marketed
- DIN 02360829 · Marketed